相关实验视频

Updated: Jun 9, 2025

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

通过马拉酸脱酶2对质母细胞干细胞表转录组的代谢调节

Deguan Lv¹, Deobrat Dixit², Andrea F Cruz³

¹UPMC Hillman Cancer Center, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Cell metabolism

|October 25, 2024

概括

质母细胞通过马酸脱酶2 (MDH2) 重新编程新陈代谢,影响RNA的修改. 向MDH2为脑瘤提供了一个潜在的治疗策略.

科学领域:

癌症新陈代谢癌症新陈代谢
质母细胞的干细胞
史诗转录组学史诗转录组学
生物化学路径生物化学路径

背景情况:

瘤表现出代谢重编程以支持瘤生长.
质母细胞 (GSCs) 具有独特的代谢依赖性.
酸马酸-酸盐 (MAS) 和酸马酸脱酶2 (MDH2) 涉及到细胞代谢.

研究的目的:

研究MDH2在质母细胞干细胞代谢和功能中的作用.
探索MDH2活性,αKG水平和RNA修饰之间的联系.
评估MDH2作为质母细胞瘤的治疗点.

主要方法:

在GSC中评估MDH2表达和MAS活性.
利用遗传学和药理学方法来准MDH2.2.
测量了αKG积累,m6ARNA水平和ALKBH5活动.
研究了MDH2抑制和达沙替尼的联合疗效.

主要成果:

GSCs显示MDH2活性升高和MAS功能.
针对MDH2减少了GSC的扩散,自我更新和瘤生长,阿斯巴酸盐部分挽救.
抑制MDH2导致αKG积累和降低全球m6A水平,影响PDGFRβ转录.
结合MDH2抑制和达沙替尼增强了抗瘤作用.

结论:

MDH2对于GSC的增殖和自我更新至关重要,它将细胞代谢与表皮转录学调节联系起来.
向MDH2会破坏αKG恒温和m6A的修饰,影响关键的与癌症相关的转录.
抑制MDH2是一种有前途的治疗策略,有可能增强质母细胞瘤的现有治疗方法.

关键词:

在 ALKBH5H5 中 MDH2MDH2 MDH2 MDH2 MDH2 MDH2 MDH2 MDH2 MDH2 这是PDGFRββ.阿尔法-基质酸盐的使用.癌症干细胞是一种癌症干细胞.标志性转录组学标志性转录组学质母细胞瘤 (glioblastoma) 是一种 m6A 一个很好的.马拉酸-阿斯巴酸盐的穿车.代谢过程中的代谢.

更多相关视频

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

MitoCeption: Transferring Isolated Human MSC Mitochondria to Glioblastoma Stem Cells

MitoCeption: Transferring Isolated Human MSC Mitochondria to Glioblastoma Stem Cells

Published on: February 22, 2017

相关概念视频

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...